A look at one company’s platform approach in enabling the engineering of T-cells to identify and destroy cancer.
Mark Dudley, PhD
Advertisement
Articles by Mark Dudley, PhD
Advertisement
Latest Updated Articles
- Designing Cell Therapies to Target Solid Tumors
Published: August 13th 2020 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Praxis Reports Positive Phase III Results for Ulixacaltamide in Essential Tremor
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
4
After the Trial is too Late: The Case for More Active Use of Patient-Reported Outcomes in Oncology Studies
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
